In silico model development and optimization of in vitro lung cell population growth

PLoS One. 2024 May 15;19(5):e0300902. doi: 10.1371/journal.pone.0300902. eCollection 2024.

Abstract

Tissue engineering predominantly relies on trial and error in vitro and ex vivo experiments to develop protocols and bioreactors to generate functional tissues. As an alternative, in silico methods have the potential to significantly reduce the timelines and costs of experimental programs for tissue engineering. In this paper, we propose a methodology to formulate, select, calibrate, and test mathematical models to predict cell population growth as a function of the biochemical environment and to design optimal experimental protocols for model inference of in silico model parameters. We systematically combine methods from the experimental design, mathematical statistics, and optimization literature to develop unique and explainable mathematical models for cell population dynamics. The proposed methodology is applied to the development of this first published model for a population of the airway-relevant bronchio-alveolar epithelial (BEAS-2B) cell line as a function of the concentration of metabolic-related biochemical substrates. The resulting model is a system of ordinary differential equations that predict the temporal dynamics of BEAS-2B cell populations as a function of the initial seeded cell population and the glucose, oxygen, and lactate concentrations in the growth media, using seven parameters rigorously inferred from optimally designed in vitro experiments.

MeSH terms

  • Cell Line
  • Cell Proliferation*
  • Computer Simulation*
  • Epithelial Cells / cytology
  • Epithelial Cells / metabolism
  • Glucose / metabolism
  • Humans
  • Lung* / cytology
  • Lung* / metabolism
  • Models, Biological*
  • Oxygen / metabolism
  • Tissue Engineering / methods

Grants and funding

This study is funded in part by a Collaborative Health Research Project (CHRP) grant provided by the Canadian Institutes of Health Research (CIHR) in partnership with the Natural Sciences and Engineering Research Council of Canada (NSERC). The study is also supported by New Frontiers in Research Fund – Transformation stream (NFRF-T), and University of Toronto’s Medicine by Design (MbD) initiative, which receives funding from the Canada First Research Excellence Fund (CFREF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.